Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page
Provident Healthcare Partners Provident Healthcare Partners

Q2 2024 Oncology Update

Provident Healthcare Partners
Skip to the end of the Expertise Menu

Q2 2024 Oncology Update

Oncology practice management continues to be one of the most active spaces in healthcare M&A, represented by 12 transactions closed through Jun-24 and marking a pace for a record year. Interest remains strong among the investor community as strategic consolidators such as American Oncology Network, OneOncology, and US Oncology Network continue to look to partner with independent physician-owned practices. Provident expects that there will be at least one new oncology platform established in 2024, which will further drive competition for add-on acquisitions. For groups that may not be platform caliber, the larger buyer pool will also provide the opportunity to explore additional partner options. Additionally, there are several groups who, historically, were adamant about remaining independent, but are now exploring the possibility of a strategic partnership, and as a result have created excitement among the investor community. As the most active investment bank within oncology, please reach out and we would welcome further discussion.

To print and download the full Oncology Update report, please click below…

[holo_button icon=”/wp-content/uploads/2024/07/Q2-2024-Oncology-vF.pdf”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]